A detailed history of Bryce Point Capital, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Bryce Point Capital, LLC holds 96,550 shares of ROIV stock, worth $1.01 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
96,550
Holding current value
$1.01 Million
% of portfolio
0.33%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$11.16 - $12.71 $1.08 Million - $1.23 Million
96,550 New
96,550 $1.14 Billion

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $7.35B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Bryce Point Capital, LLC Portfolio

Follow Bryce Point Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryce Point Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bryce Point Capital, LLC with notifications on news.